What does severe mitral annular calcification (MAC) on echocardiography indicate about the mitral valve?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Severe MAC on Echo: Clinical Significance and Implications

Severe mitral annular calcification (MAC) on echocardiography indicates extensive calcium deposition (>270° of annular circumference, >10mm thickness) that typically extends into both mitral leaflets, the anterior commissure, or subvalvular structures, causing mitral valve dysfunction (stenosis, regurgitation, or both) and signaling substantially increased cardiovascular morbidity and mortality risk. 1

Anatomic Definition of Severe MAC

Severe MAC is specifically defined by the following CT-based criteria 1:

  • Circumferential involvement: >270° of the mitral annulus
  • Thickness: >10 mm calcium bar
  • Extension: Involvement of both leaflets, anterior commissure, OR subvalvular extension into the left ventricle

This represents a chronic degenerative process where dystrophic calcium progressively deposits in the fibrous mitral annulus, typically starting at the posterior annulus mid-hinge point and extending anteriorly toward the trigones and vertically into the LV 1.

Functional Consequences

Direct Valvular Effects

The calcium deposition causes upward deformity of the leaflets, resulting in:

  • Mitral stenosis (most common with severe MAC)
  • Mitral regurgitation
  • Mixed lesions (both stenosis and regurgitation)

The petrification restricts normal annular motion and leaflet excursion, fundamentally impairing valve function 1.

Hemodynamic Impact

In natural history studies, patients with severe MAC and mean mitral valve gradient >18 mmHg or pulmonary artery systolic pressure >50 mmHg had particularly poor outcomes, with 1-year survival of only 72% 1.

Prognostic Implications

Severe MAC is independently associated with markedly increased cardiovascular risk 1:

  • Cardiovascular death and all-cause mortality (demonstrated in Framingham Heart Study)
  • Acute myocardial infarction
  • Stroke and systemic embolization
  • Atrial fibrillation
  • Conduction defects
  • Heart failure with preserved ejection fraction
  • Infective endocarditis (29% mortality when requiring surgery) 1

This is not merely a marker of age—MAC represents active cardiovascular disease with inflammatory and calcific activity that progresses over time 1.

Critical Management Implications

Mandatory Multidisciplinary Evaluation

All cases of moderate and severe MAC in high-risk patients with mitral valve disease MUST be evaluated by a multispecialty heart valve team (Class I recommendation) 1. This is non-negotiable because:

  • Standard STS risk scores significantly underestimate surgical risk in MAC patients
  • Surgical mortality is 9.9% vs 4.2% in non-MAC patients 2
  • Stroke rates are 4.7% vs 1.6% 2
  • Renal failure rates are 8.7% vs 4.3% 2

Imaging Requirements

When severe MAC is identified on echo, CT imaging is mandatory (Class I) to assess 1:

  • Exact circumferential extent and distribution
  • Calcium thickness and depth
  • Trigonal involvement
  • Subvalvular extension
  • Operative planning feasibility

Echo alone is insufficient for surgical planning in severe MAC.

Intervention Considerations

For asymptomatic or mildly symptomatic patients (NYHA I-II) with severe MAC, watchful waiting with guideline-directed medical therapy may be preferred over intervention (Class IIb) 1. The surgical/procedural risk often outweighs potential benefit in this population.

For symptomatic patients requiring intervention:

  • Transcatheter mitral valve replacement (TMVR) or hybrid approaches are reasonable in selected high-risk patients (Class IIa) 1
  • Conventional surgery carries very high risk and should only be performed at comprehensive valve centers with >50 mitral cases/year 1
  • Patients should be referred to experienced centers (Class IIa) 1

Common Pitfalls to Avoid

  1. Don't rely on pressure half-time for assessing mitral stenosis severity in MAC—it's unreliable 3
  2. Don't use planimetry alone—calcium shadowing makes this inaccurate
  3. Don't underestimate surgical risk based on standard risk calculators
  4. Don't intervene on minimally symptomatic patients—risk often exceeds benefit
  5. Don't forget to evaluate for concomitant valvular disease—aortic stenosis coexists in 17% of cases 4

Associated Comorbidities

Severe MAC typically occurs in patients with 1:

  • Advanced age (especially >70 years)
  • Chronic kidney disease/end-stage renal disease
  • Hypertension, diabetes, hyperlipidemia
  • Aortic stenosis or hypertrophic cardiomyopathy
  • History of mediastinal radiation
  • Warfarin use (possible association)

The presence of severe MAC should prompt comprehensive cardiovascular risk assessment, as it signals systemic atherosclerotic disease and elevated risk across multiple vascular beds 5, 6.

References

3
Research

Mitral Annular Calcification and Calcific Mitral Stenosis: Role of Echocardiography in Hemodynamic Assessment and Management.

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 2021

Related Questions

What is the recommended treatment for mitral annular calcification (MAC) detected on echocardiography?
Is it safe to take metoprolol in a patient with a calcified heart valve?
What is the management plan for a patient with left ventricular ejection fraction (LVEF) of 50-55%, grade I diastolic dysfunction, and mild mitral annular calcification?
How should calcific mitral valve leaflets be evaluated and managed?
In a patient with asymmetric septal hypertrophy, impaired left ventricular relaxation, mild aortic valve sclerosis without significant stenosis, and mild mitral annular calcification, what is the next recommended step and which medication should be initiated?
What are the causes of virilization?
In a patient who after 48 hours shows only partial improvement and still has frontal headache and a cough that worsens when lying down, what management steps should be taken?
Is a CT scan with intravenous contrast appropriate for evaluating suspected kidney stones?
For a post‑menopausal woman with irritability, cognitive fog, and insomnia who cannot take hormone replacement therapy, which medications can be used?
What is the appropriate management of a dog bite wound in an 86‑year‑old female patient?
After a repeat transurethral resection of bladder tumor (TURBT), how long should the Foley catheter remain in place?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.